APG-115 in Patients With Advanced Solid Tumors or Lymphomas
- First Posted Date
- 2016-10-18
- Last Posted Date
- 2022-07-12
- Lead Sponsor
- Ascentage Pharma Group Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT02935907
- Locations
- 🇺🇸
The START Center for Cancer Care, San Antonio, Texas, United States
🇺🇸START Midwest, Grand Rapids, Michigan, United States
© Copyright 2024. All Rights Reserved by MedPath